Nevirapine Extended-Release Tablets and Recombinate recombinant
Determining the interaction of Nevirapine Extended-Release Tablets and Recombinate recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: nevirapine
Brand name: Viramune, Viramune XR
Synonyms: Nevirapine
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant), Recombinate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Nevirapine Extended-Release Tablets-Recombivax
- Nevirapine Extended-Release Tablets-Recombivax HB
- Nevirapine Extended-Release Tablets-Recombivax HB Adult
- Nevirapine Extended-Release Tablets-Recombivax HB Dialysis Formulation
- Nevirapine Extended-Release Tablets-Recombivax HB Pediatric/Adolescent
- Nevirapine Extended-Release Tablets-Recort Plus
- Recombinate recombinant-Nevirapine Oral Suspension
- Recombinate recombinant-Nevirapine Suspension
- Recombinate recombinant-Nevirapine Tablets
- Recombinate recombinant-New Day
- Recombinate recombinant-New Terocin
- Recombinate recombinant-Nexa Plus